Comparison of Pathway Referrals for Liver Fibrosis Risk Stratification Performed in Diabetology and Nutrition Clinics

Authors: Caussy C, Telliam C, Al-Nuaimi B, Maynard-Muet M, Dumortier J, Zoulim F, Disse E, Colin C, Levrero M, Moulin P

Source: Diabetes, Metabolic Syndrome and Obesity, Vol Volume 16, Pp 1721-1729 (2023)

Subject Terms: nonalcoholic fatty liver disease, fibroscan, cirrhosis, transient elastography, obesity, type 2 diabetes, screening, Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: https://www.dovepress.com/comparison-of-pathway-referrals-for-liver-fibrosis-risk-stratification-peer-reviewed-fulltext-article-DMSO; https://doaj.org/toc/1178-7007

Access URL: https://doaj.org/article/d791f476df9a45a69bcc3ece46913250

Obesity, bariatric surgery: what are the real risks associated with Covid-19?

Authors: Caussy, C.

Source: Correspondances en MHDN. 25(2):60-63

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626438839&indx=1&recIds=ETOCRN626438839

Identification des répondeurs au traitement par exénatide ou liraglutide : résultats de deux études en vie réelle

Alternate Title: Identification of responders to treatment with exenatide or liraglutide: Results of two real-life studies (English)

Authors: Groza, L., Caussy, C., Moulin, P., Ziegler, O., Fay, R., Raccah, D., Vergès, B., Delemer, B., Picard, S., Gourdy, P., Guerci, B.

Source: In Médecine des maladies métaboliques February 2018 12(1):62-68

EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

Authors: Blond, E., Disse, E., Cuerq, C., Drai, J., Valette, P. J., Laville, M., Thivolet, C., Simon, C., Caussy, C.

Source: DIABETOLOGIA. 60(7):1218-1222

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN384242650&indx=1&recIds=ETOCRN384242650

Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes

Authors: Jehl, A., Cugnet-Anceau, C., Vigouroux, C., Legeay, A. L., Dalle, S., Harou, O., Marchand, L., Lascols, O., Caussy, C., Thivolet, C.

Source: Diabetes care. 42(10):2008-2010

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN621492844&indx=1&recIds=ETOCRN621492844

Lack of evidence for a liver or intestinal miRNA regulation involved in the hypertriglyceridemic effect of APOC3 3′UTR variant SstI

Authors: Dancer, M., Caussy, C., Di Filippo, M., Moulin, P., Marçais, C., Charrière, S.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 255:6-10

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN381974520&indx=1&recIds=ETOCRN381974520

Statins in secondary prevention of cardiovascular risk

Authors: Caussy, C., Charrière, S., Moulin, P.

Source: Revue du praticien. 66(3):322-326

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN605369337&indx=1&recIds=ETOCRN605369337

Multiple microRNA regulation of lipoprotein lipase gene abolished by 3′UTR polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter

Authors: Caussy, C., Charrière, S., Meirhaeghe, A., Dallongeville, J., Lefai, E., Rome, S., Cuerq, C., Euthine, V., Delay, M., Marmontel, O.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 246:280-286

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN375536314&indx=1&recIds=ETOCRN375536314

An APOA5 3′ UTR Variant Associated with Plasma Triglycerides Triggers APOA5 Downregulation by Creating a Functional miR-485-5p Binding Site

Authors: Caussy, C., Charrière, S., Marçais, C., Di Filippo, M., Sassolas, A. s., Delay, M., Euthine, V., Jalabert, A., Lefai, E., Rome, S.

Source: AMERICAN JOURNAL OF HUMAN GENETICS. 94(1):129-134

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN345383746&indx=1&recIds=ETOCRN345383746

Determining the metabolic flexibility response to a multi-fiber diet: A randomized-controlled trial

Authors: Aubin, A., Ranaivo, H., Simon, C., Van Den Berghe, L., Feugier-Favier, N., Hornero-Ramirez, H., Dussous, I., Roger, L., Laville, M., Bera-Maillet, C., Doré, J., Caussy, C., Nazare, J.-A.

Source: In Clinical Nutrition ESPEN December 2023 58:610-610

Semaglutide for patients with severe obesity: characteristics of a real word cohort and early effect on weight after 6 months

Authors: Noelle, H., Segrestin, B., Benatre, V., Caussy, C., Disse, E.

Source: In Clinical Nutrition ESPEN December 2023 58:547-547

Magnetic Resonance Elastography versus Transient Elastography in detection of fibrosis in nonalcoholic fatty liver disease: A systematic review and meta-analysis of individual participant date

Authors: Hsu, C., Caussy, C., Imajo, K., Chen, J., Singh, S., Kaulback, K., Le, M., Hooker, J., Bettencourt, R., Yin, M., Sirlin, C., Ehman, R.L., Nakajima, A., Loomba, R.

Source: Journal of hepatology. 68(S1):S560-S561

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100059932939.0x000001&indx=1&recIds=ETOCvdc_100059932939.0x000001

Serum bile acids alteration is associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD

Authors: Caussy, C., Hsu, C., Seema, S., Shirin, B., James, K., Faulkner, C., Bettencourt, R., Valasek, M., Richards, L., David, B., Loomba, R.

Source: Journal of hepatology. 68(S1):S30-S31

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100057736717.0x000001&indx=1&recIds=ETOCvdc_100057736717.0x000001

Chapitre 21 - Stéatose hépatique de l’enfant: Non alcoholic fatty liver disease (NAFLD) et stéatohépatite non alcoolique (NASH)

Authors: Caussy, C., Peretti, N.

Source: In Hépatologie de l’enfant 2018:141-146

Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort

Authors: Brandman, D., Boyle, M., McPherson, S., Van Natta, M., Sanyal, A., Kowdley, K., Tetri, B., Chalassani, N., Abdelmalek, M., Terrault, N.A., McCullough, A., Bettencourt, R., Caussy, C., Kleiner, D., Behling, C., Doo, E., Tonascia, J., Anstee, Q., Loomba, R.

Source: Journal of hepatology. 66(1):S69-S70

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050871205.0x000001&indx=1&recIds=ETOCvdc_100050871205.0x000001

Systematic assay of lipoprotein lipase activity and mass in cohort of patients with history of type V hyperlipidemia

Authors: Marmontel, O., di Filippo, M., Nony, S., Marcais, C., Caussy, C., Charriere, S., Sassolas, A., Moulin, P.

Source: Atherosclerosis. 252:e99-e100

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100059785382.0x000001&indx=1&recIds=ETOCvdc_100059785382.0x000001

Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD

Authors: Caussy, C., Hsu, C., Min-Tzu, L., Amy, L., Bettencourt, R., Ajmera, V., Shirin, B., Hooker, J., Ethan, S., Richards, L., Schork, N., Schnabl, B., David, B., Sirlin, C., Chi-Hua, C., Loomba, R.

Source: Journal of hepatology. 68(S1):S29-S29

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100059932295.0x000001&indx=1&recIds=ETOCvdc_100059932295.0x000001

Even modest alcohol use is associated with greater steatosis on magnetic resonance imaging in patients with NAFLD – a pilot study

Authors: Ajmera, V., Le, M., Caussy, C., Nguyen, P., Hernandez, C., Bettencourt, R., Behling, C., Valasek, M., Faulkner, C., Rizo, E., Richards, L., Sirlin, C., Loomba, R.

Source: Journal of hepatology. 68(S1):S837-S837

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100057733182.0x000001&indx=1&recIds=ETOCvdc_100057733182.0x000001

Évaluation de la valeur ajoutée du score calcique coronarien dans le reclassement du risque cardiovasculaire chez le diabétique de type 2 en prévention primaire

Authors: Balaire, L., Marsot, C., Moret, M., Groisne, L., Villar-Fimbel, S., Villard, A., Lecus, A., Caussy, C., Langrand, C., Charriere, S., Moulin, P.

Source: Annales d'endocrinologie. 78(4):296-296

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185697818.0x000001&indx=1&recIds=ETOCvdc_100185697818.0x000001

SAT-515 - Even modest alcohol use is associated with greater steatosis on magnetic resonance imaging in patients with NAFLD – a pilot study

Authors: Ajmera, V., Le, M., Caussy, C., Nguyen, P., Hernandez, C., Bettencourt, R., Behling, C., Valasek, M., Faulkner, C., Rizo, E., Richards, L., Sirlin, C., Loomba, R.

Source: In Journal of Hepatology April 2018 68 Supplement 1:S837-S837